Johnson & Johnson is a global American pharmaceutical and consumer goods company with headquarters in New Brunswick, New Jersey. The company is listed in the Dow Jones Industrial Average.
As of May 2024 Johnson & Johnson has a market cap of $357.92 Billion. This makes Johnson & Johnson the world's 25th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Market cap | Change |
---|---|---|
2024 | $357.92 B | -5.14% |
2023 | $377.31 B | -18.3% |
2022 | $461.84 B | 2.55% |
2021 | $450.35 B | 8.7% |
2020 | $414.30 B | 7.89% |
2019 | $384.00 B | 11.77% |
2018 | $343.57 B | -8.47% |
2017 | $375.36 B | 19.76% |
2016 | $313.43 B | 10.28% |
2015 | $284.22 B | -2.34% |
2014 | $291.04 B | 12.66% |
2013 | $258.34 B | 32.64% |
2012 | $194.77 B | 8.76% |
2011 | $179.08 B | 5.44% |
2010 | $169.85 B | -4.42% |
2009 | $177.71 B | 7.05% |
2008 | $166.00 B | -12.37% |
2007 | $189.44 B | -0.82% |
2006 | $191.01 B | 6.85% |
2005 | $178.76 B | -5.12% |
2004 | $188.42 B | 22.89% |
2003 | $153.32 B | -3.83% |
2002 | $159.42 B | -11.47% |
2001 | $180.09 B |
On May 7th, 2024 the market cap of Johnson & Johnson was reported to be:
Name | Market cap | Market cap differencediff. | Country |
---|---|---|---|
Novartis NVS | $202.14 B | -43.52% | ๐จ๐ญ Switzerland |
Pfizer PFE | $157.24 B | -56.07% | ๐บ๐ธ USA |
Abbott Laboratories ABT | $184.69 B | -48.40% | ๐บ๐ธ USA |
Medtronic MDT | $108.74 B | -69.62% | ๐ฎ๐ช Ireland |
Eli Lilly LLY | $739.19 B | 106.52% | ๐บ๐ธ USA |
Sanofi SNY | $123.74 B | -65.43% | ๐ซ๐ท France |
Gilead Sciences GILD | $81.62 B | -77.19% | ๐บ๐ธ USA |
Stryker Corporation SYK | $126.52 B | -64.65% | ๐บ๐ธ USA |
Merck MRK | $330.22 B | -7.74% | ๐บ๐ธ USA |
GlaxoSmithKline GSK | $90.07 B | -74.83% | ๐ฌ๐ง UK |